Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, has launched the authorized generic of Detrol LA (tolterodine tartrate extended-release capsules) 2 mg and 4 mg in the US market.

Detrol LA had annual sales of approximately $571.5 million in the US, according to IMS data as of September 30, 2013.

Detrol is a registered trademark of Pfizer Enterprises Sarl.

Teva Pharmaceutical Industries Ltd. is committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.